Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional)
ID: 359889Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359889
Timeline
    Description

    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award in Clinical Oncology (K12), aimed at enhancing the training of clinical scientists in cancer research. This grant program is designed to support institutional research career development programs that will increase the number of clinician-scientists engaged in clinical and translational cancer research, fostering their career development through tailored mentorship and individualized plans. The program will fund a total of 15 awards, with support for a minimum of two years and a maximum of three years for each scholar, covering salary, research, and administrative costs. Interested applicants can reach out to Mark Damico, Ph.D., at damicomw@nih.gov or call 240-276-5630 for further information, with the estimated synopsis posting date on December 1, 2025, and applications expected to close by February 18, 2026.

    Point(s) of Contact
    Mark Damico, Ph.D. National Cancer Institute (NCI)
    (240) 276-5630
    damicomw@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award for Clinical Oncology (K12), aimed at supporting institutional research career development programs for clinical scientists in cancer research. This initiative emphasizes training for clinical scientists who aspire to lead independent clinical trials or contribute to existing trials, thereby enhancing the field of clinical cancer research. The NOFO is anticipated to be released in November 2024, with the first application deadline set for February 2025, and the estimated award date is January 5, 2026. Interested applicants are encouraged to begin developing collaborations and applications in advance, as there are no cost-sharing requirements associated with this grant opportunity.
    Notice of Intent to Publish a Funding Opportunity Announcement for Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Academic Career Excellence (ACE) Award (K32), which requires an independent clinical trial. This grant aims to support late-stage graduate students and early-stage postdoctoral scholars in cancer research, specifically targeting those transitioning to postdoctoral positions or within the first two years of their postdoctoral training. The ACE Award is crucial for enhancing the scientific research and career development of candidates, as it provides essential training support and encourages the development of a robust research plan with a designated mentor. Interested applicants should note that the first due date for submissions is anticipated to be June 12, 2025, with an estimated award date of March 2, 2026. For further details, applicants can refer to the NIH website or contact the agency directly.
    Notice of Intent to Publish a Funding Opportunity Announcement for Academic Career Excellence (ACE) Award (K32 � Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the upcoming Academic Career Excellence (ACE) Award (K32), aimed at supporting late-stage graduate students and early-stage postdoctoral scholars in cancer research. This grant opportunity is designed to enhance the scientific research and career development experience of candidates transitioning to postdoctoral positions, requiring applicants to have a well-defined research and training plan with an identified mentor. The ACE Award is critical for fostering the next generation of cancer researchers, with applications expected to open on June 12, 2025, and an estimated award date of March 2, 2026. Interested applicants should prepare their proposals in advance, as there are no cost-sharing requirements, and the funding will be available under CFDA number 93.398.
    Notice of Intent to Publish Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is planning to publish a Notice of Funding Opportunity for the NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32), which will support early postdoctoral fellows in cancer research. This grant program aims to enhance the pool of qualified individuals from diverse backgrounds for careers in health-related research, particularly in cancer, by providing research training opportunities that do not require preliminary data. The program is significant for addressing cancer health disparities and enriching the scientific research experience for trainees transitioning from pre-doctoral to post-doctoral training. Interested applicants must identify a postdoctoral research mentor and submit their applications through their respective institutions, with the application deadline set for June 12, 2025, and an estimated award date of March 2, 2026.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at training individuals with clinical doctoral degrees for impactful careers in health-related research, particularly in cancer studies. This program is designed to support individuals from underrepresented backgrounds in health-related sciences, providing them with a mentored research career development experience over a period of 3 to 5 years, focusing on biomedical, behavioral, and clinical research, including clinical trials. Successful applicants are expected to commit at least 75% of their time to the project and will receive funding for salary and research-related expenses, with applications due at specific intervals starting January 12, 2025. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-319.html.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at fostering diversity within the cancer research workforce. This grant supports clinical scientists with doctoral degrees who are underrepresented in health-related research, providing salary support for a 3-5 year period to gain intensive research training in various cancer research fields, particularly focusing on health disparities. The program is designed to enhance the research capabilities of awardees, preparing them for independent research careers in basic biomedical, behavioral, or translational cancer research. Interested applicants should note that the application period opens on January 12, 2025, with a submission deadline of February 12, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-320.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI Pathway to Independence Award (K99/R00 � Independent Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the NCI Pathway to Independence Award (K99/R00), which includes an optional independent clinical trial component. This program aims to support talented postdoctoral researchers with up to six years of postdoctoral research training experience, facilitating their transition to independent tenure-track faculty positions while providing essential NCI research support to help launch their careers in cancer research. The estimated synopsis post date is November 1, 2024, with applications expected to close by February 14, 2025, and awards anticipated to be made by January 2, 2026. Interested applicants are encouraged to prepare their proposals in advance, as there are no cost-sharing requirements associated with this grant opportunity.
    The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award (K22), a federal grant aimed at supporting researchers transitioning from mentored, non-independent positions to their first independent tenure-track faculty roles in cancer research. This grant provides funding for up to three years, covering both salary and research development expenses, with the goal of enhancing the applicant's potential to secure independent NIH grants and fostering a diverse pool of capable scientists in the biomedical field. Eligible applicants include various institutions and organizations, particularly those serving underrepresented groups, and must adhere to detailed application guidelines. Interested parties can find more information and apply before the closing date of November 12, 2025, by visiting the NIH grants website or contacting NIH Grants Information at grantsinfo@nih.gov.
    NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award (K99/R00), a federal grant designed to support postdoctoral researchers transitioning to independent faculty positions in cancer research. This program provides funding for up to five years, consisting of a two-year mentored phase (K99) followed by up to three years of independent research support (R00), contingent upon securing a tenure-track position. The initiative aims to foster a diverse and skilled workforce in biomedical research, addressing critical health needs while promoting the career development of emerging investigators. Interested applicants must hold a clinical or research doctorate and have no more than six years of postdoctoral experience at the time of application. The application period opens on January 13, 2025, with a submission deadline of October 14, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-135.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 � Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the upcoming availability of the NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32), which will support early postdoctoral fellows in cancer research. This grant program aims to enhance the pool of qualified individuals from diverse backgrounds for careers in health-related research, particularly in cancer research, by providing research training opportunities without requiring preliminary data. The application process will open on June 12, 2025, with an estimated award date of March 1, 2026, and interested applicants must identify a postdoctoral mentor and submit their applications through their respective institutions. For more information, applicants can refer to the NIH website or contact the agency directly.